Disease mutant analysis identifies a new function of DAXX in telomerase regulation and telomere maintenance

Journal of Cell Science

Volumn 128, Issue 2, 2015, Pages 331-341

  Tang, Mengfan ^a   Li, Yujing ^a   Zhang, Yi ^b   Chen, Yuxi ^a   Huang, Wenjun ^a   Wang, Dan ^a   Zaug, Arthur J ^c   Liu, Dan ^b   Zhao, Yong ^a   Cech, Thomas R ^c   Ma, Wenbin ^a   Songyang, Zhou ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Cancer; DAXX; Telomerase; Telomere

Indexed keywords

DAXX PROTEIN; TELOMERASE; DAXX PROTEIN, HUMAN; DNA HELICASE; NUCLEAR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ARTICLE; COILED BODY; CONTROLLED STUDY; GENE CONTROL; GENETIC ANALYSIS; HUMAN; MUTANT; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RNA INTERFERENCE; TELOMERE; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING; ANTAGONISTS AND INHIBITORS; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; METABOLISM; MUTATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; COILED BODIES; DNA HELICASES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MUTATION; NUCLEAR PROTEINS; RNA INTERFERENCE; TELOMERASE; TELOMERE; TELOMERE HOMEOSTASIS;

EID: 84921342059     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.159467     Document Type: Article

References (49)

1. Assié, G., Letouzé, E., Fassnacht, M., Jouinot, A., Luscap, W., Barreau, O., Omeiri, H., Rodriguez, S., Perlemoine, K., René-Corail, F. et al. (2014). Integrated genomic characterization of adrenocortical carcinoma. Nat. Genet. 46, 607-612.
2. Blackburn, E. H. (1992). Telomerases. Annu. Rev. Biochem. 61, 113-129.
3. Chai, W., Ford, L. P., Lenertz, L., Wright, W. E. and Shay, J. W. (2002). Human Ku70/80 associates physically with telomerase through interaction with hTERT. J. Biol. Chem. 277, 47242-47247.
4. Cioce, M. and Lamond, A. I. (2005). Cajal bodies: a long history of discovery. Annu. Rev. Cell Dev. Biol. 21, 105-131.
5. Collins, K. (2006). The biogenesis and regulation of telomerase holoenzymes. Nat. Rev. Mol. Cell Biol. 7, 484-494.
6. Cong, Y. S., Wright, W. E. and Shay, J. W. (2002). Human telomerase and its regulation. Microbiol. Mol. Biol. Rev. 66, 407-425.
7. Cristofari, G., Adolf, E., Reichenbach, P., Sikora, K., Terns, R. M., Terns, M. P. and Lingner, J. (2007). Human telomerase RNA accumulation in Cajal bodies facilitates telomerase recruitment to telomeres and telomere elongation. Mol. Cell 27, 882-889.
8. Ding, L., Ley, T. J., Larson, D. E., Miller, C. A., Koboldt, D. C., Welch, J. S., Ritchey, J. K., Young, M. A., Lamprecht, T., McLellan, M. D. et al. (2012). Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481, 506-510.
9. Dragon, F., Pogacić, V. and Filipowicz, W. (2000). In vitro assembly of human H/ACA small nucleolar RNPs reveals unique features of U17 and telomerase RNAs. Mol. Cell. Biol. 20, 3037-3048.
10. Drané, P., Ouararhni, K., Depaux, A., Shuaib, M. and Hamiche, A. (2010). The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3. Genes Dev. 24, 1253-1265.
11. Dulak, A. M., Stojanov, P., Peng, S., Lawrence, M. S., Fox, C., Stewart, C., Bandla, S., Imamura, Y., Schumacher, S. E., Shefler, E. et al. (2013). Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat. Genet. 45, 478-486.
12. Dunham, M. A., Neumann, A. A., Fasching, C. L. and Reddel, R. R. (2000). Telomere maintenance by recombination in human cells. Nat. Genet. 26, 447-450.
13. Elsässer, S. J., Huang, H., Lewis, P. W., Chin, J. W., Allis, C. D. and Patel, D. J. (2012). DAXX envelops a histone H3.3-H4 dimer for H3.3-specific recognition. Nature 491, 560-565.
14. Feng, L., Huang, J. and Chen, J. (2009). MERIT40 facilitates BRCA1 localization and DNA damage repair. Genes Dev. 23, 719-728.
15. Fu, D. and Collins, K. (2007). Purification of human telomerase complexes identifies factors involved in telomerase biogenesis and telomere length regulation. Mol. Cell 28, 773-785.
16. Gall, J. G. (2000). Cajal bodies: the first 100 years. Annu. Rev. Cell Dev. Biol. 16, 273-300.
17. Greenberg, R. A., Allsopp, R. C., Chin, L., Morin, G. B. and DePinho, R. A. (1998). Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene 16, 1723-1730.
18. Greider, C. W. (1996). Telomere length regulation. Annu. Rev. Biochem. 65, 337-365.
19. Hanahan, D. and Weinberg, R. A. (2000). The hallmarks of cancer. Cell 100, 57-70.
20. Harley, C. B., Futcher, A. B. and Greider, C. W. (1990). Telomeres shorten during ageing of human fibroblasts. Nature 345, 458-460.
21. Heaphy, C. M., de Wilde, R. F., Jiao, Y., Klein, A. P., Edil, B. H., Shi, C., Bettegowda, C., Rodriguez, F. J., Eberhart, C. G., Hebbar, S. et al. (2011). Altered telomeres in tumors with ATRX and DAXX mutations. Science 333, 425.
22. Herbert, B. S., Hochreiter, A. E., Wright, W. E. and Shay, J. W. (2006). Nonradioactive detection of telomerase activity using the telomeric repeat amplification protocol. Nat. Protoc. 1, 1583-1590.
23. Hoareau-Aveilla, C., Bonoli, M., Caizergues-Ferrer, M. and Henry, Y. (2006). hNaf1 is required for accumulation of human box H/ACA snoRNPs, scaRNPs, and telomerase. RNA 12, 832-840.
24. Hu, J., Hwang, S. S., Liesa, M., Gan, B., Sahin, E., Jaskelioff, M., Ding, Z., Ying, H., Boutin, A. T., Zhang, H. et al. (2012). Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer. Cell 148, 651-663.
25. Imielinski, M., Berger, A. H., Hammerman, P. S., Hernandez, B., Pugh, T. J., Hodis, E., Cho, J., Suh, J., Capelletti, M., Sivachenko, A. et al. (2012). Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 150, 1107-1120.
26. Jády, B. E., Bertrand, E. and Kiss, T. (2004). Human telomerase RNA and box H/ACA scaRNAs share a common Cajal body-specific localization signal. J. Cell Biol. 164, 647-652.
27. Jiao, Y., Shi, C., Edil, B. H., de Wilde, R. F., Klimstra, D. S., Maitra, A., Schulick, R. D., Tang, L. H., Wolfgang, C. L., Choti, M. A. et al. (2011). DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 331, 1199-1203.
28. Kanaya, T., Kyo, S., Takakura, M., Ito, H., Namiki, M. and Inoue, M. (1998). hTERT is a critical determinant of telomerase activity in renal-cell carcinoma. Int. J. Cancer 78, 539-543.
29. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L., Coviello, G. M., Wright, W. E., Weinrich, S. L. and Shay, J. W. (1994). Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015.
30. Lee, O. H., Kim, H., He, Q., Baek, H. J., Yang, D., Chen, L. Y., Liang, J., Chae, H. K., Safari, A., Liu, D. et al. (2011). Genome-wide YFP fluorescence complementation screen identifies new regulators for telomere signaling in human cells. Mol. Cell. Proteomics 10.
31. Lewis, P. W., Elsaesser, S. J., Noh, K. M., Stadler, S. C. and Allis, C. D. (2010). Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres. Proc. Natl. Acad. Sci. USA 107, 14075-14080.
32. Liu, D., Safari, A., O'Connor, M. S., Chan, D. W., Laegeler, A., Qin, J. and Songyang, Z. (2004). PTOP interacts with POT1 and regulates its localization to telomeres. Nat. Cell Biol. 6, 673-680.
33. Liu, C. P., Xiong, C., Wang, M., Yu, Z., Yang, N., Chen, P., Zhang, Z., Li, G. and Xu, R. M. (2012). Structure of the variant histone H3.3-H4 heterodimer in complex with its chaperone DAXX. Nat. Struct. Mol. Biol. 19, 1287-1292.
34. Lovejoy, C. A., Li, W., Reisenweber, S., Thongthip, S., Bruno, J., de Lange, T., De, S., Petrini, J. H., Sung, P. A., Jasin, M. et al.; ALT Starr Cancer Consortium (2012). Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLoS Genet. 8, e1002772.
35. Nandakumar, J., Bell, C. F., Weidenfeld, I., Zaug, A. J., Leinwand, L. A. and Cech, T. R. (2012). The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity. Nature 492, 285-289.
36. Ouellette, M. M., Liao, M., Herbert, B. S., Johnson, M., Holt, S. E., Liss, H. S., Shay, J. W. and Wright, W. E. (2000). Subsenescent telomere lengths in fibroblasts immortalized by limiting amounts of telomerase. J. Biol. Chem. 275, 10072-10076.
37. Pogacić, V., Dragon, F. and Filipowicz, W. (2000). Human H/ACA small nucleolar RNPs and telomerase share evolutionarily conserved proteins NHP2 and NOP10. Mol. Cell. Biol. 20, 9028-9040.
38. Schwartzentruber, J., Korshunov, A., Liu, X. Y., Jones, D. T., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A. M., Quang, D. A., Tönjes, M. et al. (2012). Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482, 226-231.
39. Shay, J. W. and Bacchetti, S. (1997). A survey of telomerase activity in human cancer. Eur. J. Cancer 33, 787-791.
40. Stransky, N., Egloff, A. M., Tward, A. D., Kostic, A. D., Cibulskis, K., Sivachenko, A., Kryukov, G. V., Lawrence, M. S., Sougnez, C., McKenna, A. et al. (2011). The mutational landscape of head and neck squamous cell carcinoma. Science 333, 1157-1160.
41. Takakura, M., Kyo, S., Kanaya, T., Tanaka, M. and Inoue, M. (1998). Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res. 58, 1558-1561.
42. Tang, J., Wu, S., Liu, H., Stratt, R., Barak, O. G., Shiekhattar, R., Picketts, D. J. and Yang, X. (2004). A novel transcription regulatory complex containing death domain-associated protein and the ATR-X syndrome protein. J. Biol. Chem. 279, 20369-20377.
43. Tomlinson, R. L., Ziegler, T. D., Supakorndej, T., Terns, R. M. and Terns, M. P. (2006). Cell cycle-regulated trafficking of human telomerase to telomeres. Mol. Biol. Cell 17, 955-965.
44. Venteicher, A. S., Meng, Z., Mason, P. J., Veenstra, T. D. and Artandi, S. E. (2008). Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly. Cell 132, 945-957.
45. Venteicher, A. S., Abreu, E. B., Meng, Z., McCann, K. E., Terns, R. M., Veenstra, T. D., Terns, M. P. and Artandi, S. E. (2009). A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis. Science 323, 644-648.
46. Wang, F., Podell, E. R., Zaug, A. J., Yang, Y., Baciu, P., Cech, T. R. and Lei, M. (2007). The POT1-TPP1 telomere complex is a telomerase processivity factor. Nature 445, 506-510.
47. Xin, H., Liu, D., Wan, M., Safari, A., Kim, H., Sun, W., O'Connor, M. S. and Songyang, Z. (2007). TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase. Nature 445, 559-562.
48. Xue, Y., Gibbons, R., Yan, Z., Yang, D., McDowell, T. L., Sechi, S., Qin, J., Zhou, S., Higgs, D. and Wang, W. (2003). The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies. Proc. Natl. Acad. Sci. USA 100, 10635-10640.
49. Zhu, Y., Tomlinson, R. L., Lukowiak, A. A., Terns, R. M. and Terns, M. P. (2004). Telomerase RNA accumulates in Cajal bodies in human cancer cells. Mol. Biol. Cell 15, 81-90.